CA125, CA199 combined with exfoliative cytometer detection for the diagnosis of Ovarian Cancer of malignant seroperitoneum

( views:589, downloads:0 )
Author:
CUI Jie(Dept. of Onchology, Shangqiu First People Hospital, Henan, Shangqiu 476100, China)
Journal Title:
CHINA CLINICAL PRACTICAL MEDICINE
Issue:
Volume 04, Issue 12, 2010
DOI:
10.3760/cma.j.issn 1673-8799.2010.12.50
Key Word:
CA125;CA199;Exfoliative cytometer detection;Ovarian cancer;Malignant seroperitoneum

Abstract: Objective To investigate the role of CA125, CA199 combined with exfoliative cytometer detection for the diagnosis of Ovarian Cancer. Methods 32 patients Ovarian Cancer with malignant seroperitoneum was detected. CA125 ,CA199 was detected with ELISA one-step method, and seroperitoneum exfoliative cytometer was detected for light microscope detection, the results were compared. Results Blood serum and seroperitoneum overall masculine response rate was 87.5%; CA199 detection overall masculine response rate was 28. 13%; seroperitoneum exfoliative cytometer detection overall masculine response rate was 53.13%;CA125, CA199 and exfoliative cytometer joint detection overall masculine response rate was 96.88%. There was significant difference about the overall response rate (P< 0. 05) between three groups, respectively. Conclusion Seroperitoneum tumor marker CA125, CA199 sensitivity is more height than simple seroperitoneum exfoliative cytometer detection, but Joint detection improve clinical diagnosis of ovarian cancer sensitivity.

  • [1]李巍,崔恒,冯捷.卵巢癌诊断的研究进展.中华妇产科杂志,2005,40(7):496-498.
  • [2]Antoneua B,Roeao V,ermelando V,et al.Serum and peritoneal fluid level in patients with endometriosis.Fertil Steril,1994,61:440.
  • [3]葛学顺.CA125、CA19-9联合检测对卵巢恶性肿瘤的诊断价值.检验医学与临床,2007,4(3):177-179.
  • [4]王一,宝建中,吴孟超,等.染色体畸变与肿瘤发生.肿瘤,1996,16(3):437.
  • [5]Santer G,Deng G.Physical deletion of the p53 gene in Bladder cancer.Am J Pathol,1994,90(3):144-156.
  • [6]秦万平,林勃.血清CA125、CA19-9、CA153联合检测在卵巢肿瘤中的运用.江西医学院学报,2006,46(5):80-84.
  • [7]Kumar P,Rehanim M,Kumar L,et al.Tumor marker CA125 as an evaluator and response indication ovarian Cancer:Its quantitative correlation with tumor volume.Med Sci Monit,2005; 11 (2):84-89.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn